Drugs and Dementia (Memory Enhancers?) | November 10, 2022
Date of Presentation: November 10, 2022
In this presentation, Eric Metterhausen, PharmD, BCPS, CPP, CPH, presents on what medications may help memory in patients with Alzheimer’s (including removal of exacerbating medications, as well as cholinesterase inhibitors, NMDA receptor antagonist, Recombinant monoclonal antibody against amyloid beta, investigational medications, and more) and the efficacy, safety, and limitations of current treatments.
Recording:
Presented by:
Eric Metterhausen, PharmD, BCPS, CPP, CPH
Eric Metterhausen, PharmD, BCPS, CPP, CPH, serves as the Advanced Clinical Pharmacist Supervisor at Cherokee Indian Hospital. He also serves as a Commander in the United States Public Health Service. He received his PharmD at University of Illinois – Chicago and subsequently became a board-certified Pharmacotherapy Specialist. He is also Certified in Public Health and licensed in North Carolina as a Clinical Pharmacist Practitioner. Eric has had a passion for teaching throughout his 10+ year career within IHS. He has served as a preceptor for over 300 pharmacy students from 18 Schools of Pharmacy. He has also served as a preceptor for pharmacy residents at his site. He was selected as an instructor for the IHS Pharmacy Practice Training Program in 2019. In his spare time, Eric likes to spend time with his family, hike, paddleboard, and play disc golf.
Resources Provided:
- To Claim CE
- Alzheimer Disease: Pharmacologic and Nonpharmacologic Therapies for Cognitive and Functional Symptoms (Am Fam Physicians)
- Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial (Lancet)
- The effectiveness and value of aducanumab for Alzheimer’s disease (JMCP)
- CMS Finalizes Medicare Coverage Policy for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease (Press Release)
- A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease (Clinical Trials)
- Low-Dose Aspirin Use and Cognitive Function in Older Age: A Systematic Review and Meta-analysis (J Am Geriatr Soc)
- Dietary fatty acids and risk for Alzheimer's disease, dementia, and mild cognitive impairment: A prospective cohort meta-analysis (Nutrition)
- Comprehensive Review on Alzheimer's Disease: Causes and Treatment (Molecules)
- Donanemab in Early Alzheimer's Disease (NEJM)
- Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity (JAMA Neurology)
- Anticholinergic Burden Scale
Date added: November 10, 2022